Quarterly report pursuant to Section 13 or 15(d)

Other Income / (Expense)

v3.23.1
Other Income / (Expense)
9 Months Ended
Mar. 31, 2023
Notes to Financial Statements  
Other Income / (Expense)

Note 11. Other Income / (Expense):

The components of other income (expense) in the accompanying Statement of Earnings and Comprehensive Income are as follows (in thousands):

Quarter Ended

Nine Months Ended

March 31, 

March 31, 

    

2023

    

2022

2023

    

2022

Interest expense

$

(1,367)

$

(2,493)

$

(7,513)

$

(8,804)

Interest income

974

168

2,375

606

Other non-operating income (expense), net(1)

 

378

 

(19,350)

 

51,062

 

14,515

Total other income (expense)

$

(15)

$

(21,675)

$

45,924

$

6,317

(1) For the quarter ended March 31, 2023, primarily due to a $0.3 million gain in the fair value of our exchange traded investment grade bond funds compared to a $18.1 million loss in the fair value of our CCXI investment and exchange traded investment grade bond funds in the comparative period. For the nine months ended March 31, 2023, primarily due to a $37.2 million gain on the sale of our CCXI investment and a $11.7 million gain on the sale of Eminence, compared to a $16.5 million gain in the fair value of our CCXI investment in the comparative period.